BridgeBio Pharma Inc (BBIO)
Healthcare
Biotechnology
80.00 $
-0.2%
vs. previous close
Closing price · As of: 3. Aug 2026
BridgeBio Pharma Inc (BBIO) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (2025), "Operating Cash Flow" came in at -446 million USD. Tick rows to compare them in a chart.
All figures in millions of USD.
| Tick rows to compare them in a chart (up to 4) | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|
| -40 | -137 | -254 | -400 | -498 | -419 | -528 | -521 | -446 | |
| 0.3 | 0.2 | 3.1 | 3.1 | 5.8 | 6.8 | 6.5 | 6.1 | 6.0 | |
| 1.8 | 6.1 | 21 | 58 | 100 | 92 | 115 | 96 | 133 | |
| -11 | -28 | 18 | 63 | 111 | 113 | – | – | – | |
| 1.2 | 22 | -11 | 15 | -4.4 | 28 | 5.1 | 32 | -51 | |
| 0.5 | 18 | 5.1 | 7.5 | 48 | 6.3 | 1.3 | 0.9 | 1.1 | |
| -0.5 | -21 | -217 | -53 | -201 | 453 | 54 | 61 | -24 | |
| 1.2 | 0.0 | 1.0 | 537 | 3.8 | – | – | – | – | |
| 107 | 431 | 369 | -76 | -205 | -1.6 | -6.9 | -7.5 | -48 | |
| 4.0 | 56 | 37 | 537 | 1,064 | -20 | 0.0 | 477 | 116 | |
| 113 | 502 | 399 | 447 | 736 | -13 | 452 | 748 | 359 | |
| 72 | 344 | -72 | -5.5 | 38 | 21 | -22 | 289 | -111 | |
| -41 | -155 | -259 | -407 | -546 | -426 | -529 | -522 | -447 |
Data as of: August 3, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.